Jawahar L. Mehta

[1] Mehta's thesis topic was "studies on experimental myocardial reperfusion" [2] which he completed under the direction of Prof. Tom Saldeen.

He completed his post-graduate training in Medicine at the Mount Sinai Medical Center in New York, followed by a research fellowship at the University of Minnesota, Minneapolis.

At the University of Florida College of Medicine, Mehta was among the first[4] to describe platelet activation as a basis of acute coronary syndromes.

[5] His work on LOX-1 receptors, its polymorphic variants and its role in atherogenesis and myocardial ischemia has led to new therapeutic targets now being pursued by several biotech companies, such as MedImmune.

[15] In the same year, the Italian Society of Cardiology and the University of Rome Tor Vergata honored him with Distinguished Professorship and Lifetime Achievement Award.

[16] In 2020, the Department of Veterans Affairs honored Dr. Mehta with the Senior Clinician Scientist Investigator (SCSI) Award in Cardiovascular Sciences.